Clinics' Stem Cell Treatments Endanger Patients, DOJ Says

By Lauren Berg · May 6, 2021, 10:47 PM EDT

The U.S. Department of Justice is asking a California federal judge to stop a pair of clinics from offering experimental stem cell treatments without approval from the U.S. Food and Drug...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

United States of America v. California Stem Cell Treatment Center, Inc. et al

Case Number

Court

California Central

Nature of Suit

Other Statutory Actions

Date Filed

May 09, 2018

Recent Articles By Lauren

April 15, 2026
'Law, Not Liturgy'?: 9th Circ. Split Over Faith Bias COVID Suit
April 14, 2026
4th Circ. Revives Pharma Bid To Block Maryland's 340B Law
April 06, 2026
RFK Jr. Tweaks HHS Vaccine Policy Panel Membership Criteria
March 18, 2026
Apple Took Masimo IP But No Remedy Warranted, Judge Says
February 27, 2026
AI-Focused Generate Biomedicines Prices $400M IPO
February 24, 2026
Ariz., Calif. Lead Suit Over 'Senseless' HHS Vaccine Overhaul
February 18, 2026
J&J Unit Appeals $442M Catheter Antitrust Loss To 9th Circ.
February 06, 2026
HHS Refers Hims & Hers To DOJ Amid Compound Drug Fight
January 30, 2026
Drugmakers Ask To Appeal Overarching Conspiracy Claim
January 27, 2026
Kelley Drye Adds Ex-23andMe, Facebook Privacy Pros